LVTX
Price
$1.57
Change
+$0.01 (+0.64%)
Updated
Sep 3 closing price
Capitalization
41.3M
69 days until earnings call
VIVS
Price
$2.52
Change
+$0.18 (+7.69%)
Updated
Sep 3 closing price
Capitalization
6.53M
Interact to see
Advertisement

LVTX vs VIVS

Header iconLVTX vs VIVS Comparison
Open Charts LVTX vs VIVSBanner chart's image
LAVA Therapeutics
Price$1.57
Change+$0.01 (+0.64%)
Volume$69.63K
Capitalization41.3M
VivoSim Lab
Price$2.52
Change+$0.18 (+7.69%)
Volume$1.24M
Capitalization6.53M
LVTX vs VIVS Comparison Chart in %
Loading...
LVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LVTX vs. VIVS commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LVTX is a StrongBuy and VIVS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (LVTX: $1.57 vs. VIVS: $2.52)
Brand notoriety: LVTX and VIVS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LVTX: 59% vs. VIVS: 337%
Market capitalization -- LVTX: $41.3M vs. VIVS: $6.53M
LVTX [@Biotechnology] is valued at $41.3M. VIVS’s [@Biotechnology] market capitalization is $6.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LVTX’s FA Score shows that 1 FA rating(s) are green whileVIVS’s FA Score has 1 green FA rating(s).

  • LVTX’s FA Score: 1 green, 4 red.
  • VIVS’s FA Score: 1 green, 4 red.
According to our system of comparison, both LVTX and VIVS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LVTX’s TA Score shows that 3 TA indicator(s) are bullish while VIVS’s TA Score has 6 bullish TA indicator(s).

  • LVTX’s TA Score: 3 bullish, 4 bearish.
  • VIVS’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, VIVS is a better buy in the short-term than LVTX.

Price Growth

LVTX (@Biotechnology) experienced а +1.29% price change this week, while VIVS (@Biotechnology) price change was +36.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.29%. For the same industry, the average monthly price growth was +15.06%, and the average quarterly price growth was +30.89%.

Reported Earning Dates

LVTX is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+0.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LVTX($41.3M) has a higher market cap than VIVS($6.53M). VIVS YTD gains are higher at: 408.806 vs. LVTX (64.038). VIVS has higher annual earnings (EBITDA): -1.72M vs. LVTX (-26.85M). LVTX has more cash in the bank: 56.2M vs. VIVS (9.06M). LVTX has less debt than VIVS: LVTX (0) vs VIVS (822K). LVTX has higher revenues than VIVS: LVTX (4.99M) vs VIVS (142K).
LVTXVIVSLVTX / VIVS
Capitalization41.3M6.53M633%
EBITDA-26.85M-1.72M1,565%
Gain YTD64.038408.80616%
P/E RatioN/AN/A-
Revenue4.99M142K3,514%
Total Cash56.2M9.06M621%
Total Debt0822K-
FUNDAMENTALS RATINGS
VIVS: Fundamental Ratings
VIVS
OUTLOOK RATING
1..100
30
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
PROFIT vs RISK RATING
1..100
92
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LVTXVIVS
RSI
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 10 days ago
87%
Bearish Trend 9 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
LVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PEPG1.200.04
+3.45%
PepGen
PDD121.691.47
+1.22%
PDD Holdings
ARW123.58-2.75
-2.18%
Arrow Electronics
DDD2.18-0.12
-5.22%
3D Systems Corp
SEI29.87-1.72
-5.44%
Solaris Energy Infrastructure Inc

LVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LVTX has been loosely correlated with VIVS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if LVTX jumps, then VIVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LVTX
1D Price
Change %
LVTX100%
-0.64%
VIVS - LVTX
42%
Loosely correlated
-4.10%
JBPHF - LVTX
38%
Loosely correlated
N/A
TCRX - LVTX
36%
Loosely correlated
-2.78%
OPORF - LVTX
32%
Poorly correlated
N/A
CRVO - LVTX
32%
Poorly correlated
+4.94%
More

VIVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIVS has been loosely correlated with LVTX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VIVS jumps, then LVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIVS
1D Price
Change %
VIVS100%
-4.10%
LVTX - VIVS
42%
Loosely correlated
-0.64%
GLTO - VIVS
38%
Loosely correlated
-5.66%
RENB - VIVS
26%
Poorly correlated
-4.41%
KRRO - VIVS
26%
Poorly correlated
-3.79%
PDSB - VIVS
26%
Poorly correlated
+0.81%
More